Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Adicionar filtros








Intervalo de ano
1.
J Health Popul Nutr ; 2007 Jun; 25(2): 127-33
Artigo em Inglês | IMSEAR | ID: sea-592

RESUMO

On 8 May 2004, the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) recommended routine administration of zinc in the management of children, aged less than five years, with acute diarrhoea. In making the recommendation, WHO and UNICEF also suggested careful monitoring for adverse events associated with routine administration of zinc, particularly unusual or excess vomiting. The study assessed, in a phase IV trial, i.e. post-marketing surveillance of zinc, the occurrence of adverse events during the first hour after the administration of the first dose of zinc in children with acute or persistent diarrhoea. The study was conducted at the Dhaka Hospital of ICDDR,B and at an outpatient clinic operated by a local health NGO-Progoti Samaj Kallyan Protisthan (PSKP), Dhaka, Bangladesh. Eligible children, aged 3-59 months, were treated with 20 mg of zinc sulphate provided in a dispersible tablet formulation. The children were observed for 60 minutes following the initial treatment with zinc for adverse events, with particular attention given to vomiting or regurgitation. During the one-year observation period, 42,440 children (male 57% and female 43%) received zinc, and 20,246 (47.8%) of them were observed. Regurgitation and/or vomiting occurred in 4,392 (21.8%) of the children; 90.8% of these children had vomiting only once, 8.7% twice, and 0.5% more than twice. No children revisited the hospital for recurrent vomiting following their discharge. A significant proportion of infants and children may experience vomiting or regurgitation, usually once, following the administration of the first dose of zinc. This is a transient phenomenon that did not impact on continuation of treatment with zinc.


Assuntos
Bangladesh/epidemiologia , Pré-Escolar , Diarreia/tratamento farmacológico , Feminino , Refluxo Gastroesofágico/induzido quimicamente , Humanos , Lactente , Masculino , Vigilância de Produtos Comercializados , Segurança , Oligoelementos/efeitos adversos , Resultado do Tratamento , Vômito/induzido quimicamente , Zinco/efeitos adversos
2.
Artigo em Inglês | IMSEAR | ID: sea-87670

RESUMO

Pseudoaneursym (PA) formation of left ventricle (LV) following acute myocardial infarction (AMI) is uncommon and is usually believed to be associated with a grave prognosis. We describe a case of 55 year old male patient presented with AMI and heart failure with a systolic murmur later diagnosed to have PA of the lateral wall of LV on echocardiography (transthoracic and transesophageal, TTE andTEE). Cardiac MRI and coronary angiogram (CAG) were performed. CAG showed 60% lesion at origin of major obtuse marginal artery (OM1). The patientwas advised surgical treatment, but he refused and took discharge against medical advice on 27th dayof admission on stable condition.


Assuntos
Falso Aneurisma/diagnóstico , Ecocardiografia Transesofagiana/métodos , Eletrocardiografia/métodos , Aneurisma Cardíaco/diagnóstico , Ruptura Cardíaca Pós-Infarto/diagnóstico , Humanos , Índia , Angiografia por Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Medição de Risco , Índice de Gravidade de Doença , Recusa do Paciente ao Tratamento
3.
Artigo em Inglês | IMSEAR | ID: sea-118543

RESUMO

BACKGROUND: HIV infection in injecting drug users (IDUs) has worked as a driving force for further spread of the virus in other population groups. Major metropolitan cities such as Mumbai, Kolkota, Chennai and Delhi have seen a diffusion of injecting drug use within the last decade. The prevalence of HIV infection among injectors ranges from 2% to 30%. Identifying effective interventional elements that have kept the prevalence of HIV low for the past 7 years among IDUs of Kolkata is thus of public health importance. METHODS: A purposive sample of opioid/opiate users was studied. Primary and secondary data on drug users, law-enforcement environment, records at drug treatment centres, jail admission data related to the 'Narcotic Drug and Psychotropic Substance Act' and interventions in other risk groups were collected. Laboratory tests for HIV, hepatitis B surface antigen and syphilis were done on consenting IDUs (n=129) and non-IDUs (n=120). For univariate and multivariate analysis, IDUs were taken as cases and non-IDUs as controls. RESULT: Of the IDUs, 2% were positive for HIV. No non-IDU was HIV-positive. Significantly more non-IDUs (10% v. 4%, p=0.05) were positive for syphilis. Sharing injection equipment within the past 6 months was reported by 71% of IDUs; sharing partners were stable and ranged from 1 to 3. More IDUs compared to non-IDUs reported being in touch with intervention programmes. The police has been tolerant to needle-syringe exchange and oral sublingual buprenorphine substitution conducted in Kolkata. Unlike in the early 1990s, non-IDUs did not switch to injecting during non-availability of brown sugar in the latter half of the 1990s and instead sought tratment. The availability of high quality heroin (>20%-50%) was low and the proportion of moderate quality heroin (>10%-20%) went up during these times due to increased police seizures. No intervention exists in jails despite the fact that a large number of drug users spend time in jail. CONCLUSION: Stable and few injection equipment-sharing partners of IDUs, launching of early targeted interventions among IDUs and sex workers in the city, police tolerance to harm reduction activities and preference of non-IDUs for detoxification during heroin draught periods have kept HIV prevalence at a low level among drug users of Kolkata for the past 7 years. immediate launching of interventions for drug users in jails seems necessary. Similar multi-pronged strategies with targeted and environmental intervention could work in other settings as well.


Assuntos
Adolescente , Adulto , Criança , Infecções por HIV/complicações , Humanos , Índia , Pessoa de Meia-Idade , Transtornos Relacionados ao Uso de Opioides/complicações , Áreas de Pobreza , Comportamento Sexual , Fatores Socioeconômicos , Abuso de Substâncias por Via Intravenosa/complicações
4.
Indian J Exp Biol ; 1989 Sep; 27(9): 802-4
Artigo em Inglês | IMSEAR | ID: sea-62500

RESUMO

In vitro effects of aspirin and paracetamol at the doses 200, 400, 600, 800 nmole/mg protein on ATPases activity were studied in the cerebrum and cerebellum of human fetus covering the age range from 10 weeks to 32 weeks of gestation. Both aspirin and paracetamol inhibit Na+K+ ATPase and Mg2+ ATPase in a dose dependent manner. The inhibition of Na+K+ ATPase and Mg2+ ATPase activity which may affect the release and uptake of biogenic amines in CNS, hinders the maturation of human fetal brain.


Assuntos
Acetaminofen/farmacologia , Adenosina Trifosfatases/metabolismo , Aspirina/farmacologia , ATPase de Ca(2+) e Mg(2+)/metabolismo , Feminino , Feto/efeitos dos fármacos , Humanos , Gravidez , ATPase Trocadora de Sódio-Potássio/metabolismo
5.
Artigo em Inglês | IMSEAR | ID: sea-19572

RESUMO

The in vitro effect of doxepin at 10, 50 and 200 micrograms/mg protein on Mg2+ and (Na+ K+)-ATPases (EC 3.6.1.3) activities of human foetal and adult brain (crude homogenate of cerebrum and cerebellum) were studied at 10-30 wk of gestation. Both Mg2+ and (Na+, K+)-ATPases of human foetal and adult brain were found to be inhibited by doxepin in a dose dependent manner. The inhibitory effect neither varied with respect to the region (i.e., cerebrum and cerebellum) nor with the gestational ages. Inhibition of ATPases activity by doxepin may affect the release and uptake of biogenic amines in the CNS, which may hamper the maturation of brain.


Assuntos
Adulto , Encéfalo/efeitos dos fármacos , ATPase de Ca(2+) e Mg(2+)/metabolismo , Doxepina/farmacologia , Feto/efeitos dos fármacos , Humanos , ATPase Trocadora de Sódio-Potássio/metabolismo
6.
Indian J Exp Biol ; 1989 Jan; 27(1): 44-6
Artigo em Inglês | IMSEAR | ID: sea-59503

RESUMO

Lorazepam (LZ), a benzodiazepine group of drug, inhibits Mg2+ and (Na+,K+) ATPases (EC 3.6.1.3) activity of human foetal and adult brain. The inhibitory effect neither varied with respect to the region (i.e. cerebrum and cerebellum) nor with the age of the foetus. The inhibition of ATPases activity indicates that the neuronal transmission processes, may be affected and raises the possibility of developmental disturbances.


Assuntos
Encéfalo/efeitos dos fármacos , ATPase de Ca(2+) e Mg(2+)/metabolismo , Feto , Humanos , Lorazepam/farmacologia , ATPase Trocadora de Sódio-Potássio/metabolismo
10.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA